When was Torus founded?

Torus was founded in 2018 and raised its 1st funding round 3 years after it was founded.

Where is Torus located?

Torus is headquartered in Cambridge, United States. It is registered at 1 Cabot Road, 4th Floor Medford, MA 02155.

How many employees does Torus have?

As of Aug 31, 2026, the latest employee count at Torus is 3.

Is Torus a funded company?

Torus is a funded company, having raised a total of $27.4M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 17, 2021.

When was the latest funding round of Torus?

Torus' latest funding was a $***** Series A round on May 05, 2021, with participation from 2 investors. Its primary sector is Infectious Diseases. In United States, the Infectious Diseases sector has seen $883M in funding in 2026 to date.

Where does Torus rank among its competitors?

Torus ranks 58th amongst 375 active competitors, of which 83 are funded. It stands 5th in terms of total funding among its competitors. The most recent competitor to raise funding was Huwel Life, which secured $5.64M in Sep, 2025.

Who are the top competitors of Torus?

Torus' top competitors include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Among them, Huwel Life secured the most recent funding round in September, 2025.

Torus - 2026 Company Profile, Team, Funding & Competitors

Company Details

Torus is a developer of smart devices for infectious disease diagnostics. It has developed SYNESTIA PLATFORM that disrupting DNA/RNA-analysis through a novel integration of microarray and qPCR technologies. It delivers comprehensive insights by putting highly multiplexed data into context to help guide clinical interventions. It provides data from blood, swab, and urine testing. It offers syndromic diagnostics solutions by delivering comprehensive microbiologic insights for patient care and medical innovation.

Website: torus.bio
Email ID: *****@torus.bio
Registered Address: 1 Cabot Road, 4th Floor Medford, MA 02155

Key Metrics

Founded Year

2018

Location

Cambridge, United States

Stage

Series A

Total Funding

$27.4M in 2 rounds

Latest Funding Round

Series A, May 05, 2021, $*****

Investors

Northpond Ventures & 1 more

Ranked

58^th among 375 active competitors

Employee Count

3 as on Aug 31, 2026

Similar Companies

Adaptive Biotechnologies & 429 more

View Torus' full profile

Torus is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Torus Biosystems Inc CIN: 83-3032622 , United States, Active	Dec 31, 2017	-	19 (As on Dec 31, 2021)	-

Torus has raised a total funding of $27.4M over 2 rounds. Its first funding round was on Mar 17, 2021. Its latest funding round was a Series A round on May 05, 2021 for $*****. 2 investors participated in its latest round. Torus has 1 institutional investor and 1 angel investor.

Here is the list of recent funding rounds of Torus:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 05, 2021	4098594	Series A	3598649	1957100	8693843	4070305
Mar 17, 2021	8646248	Seed	8234348	9321259	2412615	8172656

Access funding benchmarks and valuations. Sign up today!

View details of Torus's funding rounds and investors

The founders of Torus are Peng Yin and Dmitriy Khodakov. Shawn Marcell is the CEO of Torus.

Here are the details of Torus' key team members:

Peng Yin: Co-Founder of Torus and founder of 1 other company. They serve on the boards of 2 companies.
Dmitriy Khodakov: Co-Founder of Torus.
Shawn Marcell: Former Founder & CEO of Torus. They serve on the board of 1 company.

Torus' Board of Directors

Torus's board has 8 active members. Peng Yin, David Yu Zhang, Shawn Marcell, Adam Wiechhaus, Chenyang Victor Shi, Ben Linden, Philip Gardella and David Yu Zhang are independent board members.

Here is the list of Torus' board of directors:

Name	Type	Representing	Status	Duration
Peng Yin	Independent board member	-	Current	6y 7m
vpvsvie	Independent board member	-	Current	7y 4m
vlbamfs	Independent board member	-	Current	7y 7m
nywjgdj	Independent board member	-	Current	3y 2m
{zcjqxs	Independent board member	-	Current	2y 2m
omoapss	Independent board member	-	Current	8y 8m
tgajxnp	Independent board member	-	Current	5y 2m
uefuhqo	Independent board member	-	Current	9y 3m

View details of Torus's Founder profiles and Board Members

Torus' employee count trend

Torus has 3 employees as of Aug 26. Here is Torus's employee count trend over the years:

Uncover Torus' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Torus include Adaptive Biotechnologies, MeMed and HaystackAnalytics. Here is the list of Top 10 competitors of Torus, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Adaptive Biotechnologies 2009, Seattle (United States), Public	Provider of clinical diagnostics, and drug discovery for immune diseases	$419M	Viking Global Investors, Matrix & 21 others	72/100
2nd	MeMed 2009, Tirat Carmel (Israel), Series D	Provider of machine learning based diagnostic solutions for infectious diseases	$163M	La Maison Partners, Ping An & 23 others	69/100
3rd	HaystackAnalytics 2018, Mumbai (India), Seed	Provider of genomics technology for personalized clinical decisions	$17.3M	STRIVE, Sun Pharma & 33 others	68/100
4th	Inflammatix 2016, San Francisco (United States), Series E	Provider of diagnostic solutions for systemic infections	$191M	Khosla Ventures, Think.Health & 16 others	64/100
5th	Huwel Life 2015, Hyderabad (India), Series A	Molecular diagnostic solutions and products for the healthcare industry	$5.74M	Bartronics, BIRAC & 3 others	59/100
6th	Karius 2014, Redwood City (United States), Series C	Provider of diagnostics for identifying infectious diseases using microbial DNA	$315M	Khosla Ventures, Gilde Healthcare & 16 others	58/100
7th	Mylab 2016, Pune (India), Seed	Developer of diagnostic kits for pathogen detection and viral load monitoring	-	Rising Sun Holdings, Zydus Life & 10 others	57/100
8th	GenMark Diagnostics 1993, San Diego (United States), Acquired	Provider of instruments and test panels for multiplexed molecular diagnostics	$8.56M	SLR Investment Corp, VIDANT Capital	57/100
9th	Seegene Technologies 2000, Seoul (South Korea), Public	Provider of advanced molecular diagnostics solutions	-	IMM Investment, Songhyun Investment & 3 others	56/100
10th	Intus Bio 2014, Farmington (United States), Seed	Developer of sequencing technology for microbiome testing, pathogen identification, and tracking	$4.14M	Design Technologies, Connecticut Innovations ... & 4 others	56/100
58th	Torus 2018, Cambridge (United States), Series A	Developer of smart devices for infectious disease diagnostics	$27.4M	Northpond Ventures & 1 others	39/100